Welcome to NewsRx for Marketing, Public Relations & Media Professionals
NewsRx publishes the largest weekly database of current medical news, disease research, and business reports for the pharmaceutical and biotech industries.
Each week, we add thousands of articles to our database on women's health, obesity, vaccines, cancer, gene therapy, heart disease and more than 30 other clinical areas. Our articles are available to pharmaceutical and biotech professionals in a variety of formats, including free and subscription fee newsletters, individual and bundled medical articles sales, custom reports, competitive intelligence reports, timed access to the NewsRx site, newsfeeds, site licenses, and databases. Marketing, public relations and media professionals are welcomed at NewsRx. We encourage you to use our many free trial offers to access NewsRx content free of charge. By becoming NewsRx members -- it's free -- you also enjoy many free articles, custom reports and huge discounts on NewsRx products. Learn more about our membership. Our product descriptions, reach numbers and advertising information are described below.
What We Do
NewsRx is a 20-year-old, award-winning, Atlanta-based publisher of medical, legal and business newsletters for the biotech and pharmaceutical professional. All of our newsletters are published weekly and are in print and online at this website. For more details and some history on our company, see About Us. Click these links to learn more about our publications, see a full list and obtain sample issues.
Our Reach
NewsRx content is seen on more than 300 websites, including 146 hospital sites. Based on a December 2005 audit of all our sites, and including our print and pass alongs, we estimate that we have 462,000 unique professional and consumer readers/users per week at all our sites. At www.NewsRx.com, we have 40,000 unique professional users per week. These reach numbers are applicable to all our newsletters and content. This information is automatically updated weekly from our print and online usage statistics.
Our Advertising Policy
NewsRx accepts display and banner advertising on our site, however, we do not accept any advertising in our print or online newsletters. For more information on advertising, please contact us.
Post A Press Release, Expert, White Paper Or Op-Ed
After registering with NewsRx, registered sources may post unedited press releases on our site and these will appear at right under Today's Biotech & Pharma Press Releases for seven days, and be linked to our homepage and the Professionals and Industry Executives homepages. Posting your release, media alert, or calendar event here also ensures that it reaches NewsRx editors for possible inclusion in the appropriate newsletter. Additionally, we welcome you to post your experts, white papers and Op-Editorials here to provide resources for our editors and other reporters who use our site. These resources are posted on this homepage. Register now for free. Already registered? Login to post a release.
Depending on when in our cycle we receive your information, it can take up to 10 working days to include your release, if accepted, in a publication. You can search for it online online at www.NewsRx.com by placing your company name or release headline in the search box. You may print an HTML or PDF version of your content for $3. If you find you're printing a lot of copies, try our discounted NewsRx Bundled, which can cut your costs in half.
|
Results of the Phase III Pivotal Study of VYVANSE™ (lisdexamfetamine dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
